Watch Ticker

TransCode Therapeutics, Inc. Common Stock

Go to TransCode Therapeutics, Inc. Common Stock Website

$11.47

0.07 (0.61%)

Live

Previous Close

$11.4

Day Range

$11.37 - $12.1

Previous Day Range

$10.755 - $11.635

Market Cap

$9.6 million USD

Day Vol.

13675

Previous Day Vol.

42220

Currency

USD

Primary Exchange

Nasdaq

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therap...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Rishabh Mishra - US Stocks Likely To Open Lower After S&P 500's 9-Day Streak: 'Any De-Escalation In Trade Tensions Should Be Positive,' Says Expert

U.S. stock futures fell on Monday after a nine-day winning streak on the S&P 500 index. Investors will keep an eye on the Federal Reserve's decision on interest rates this week. Analysts say any de-escalation in trade tensions should be positive for the economy and financial markets.

Related tickers: BON, CMI, F, FpB, FpC, FpD, FFAI, FFAIW, HSIC, PLRZ, QQQ, RNAZ, SPY, TSN.

Read Full Article

Henry Khederian - Why Transcode Therapeutics (RNAZ) Stock Is Down 60% - Benzinga

Transcode Therapeutics (RNAZ) stock is trading 62% lower after the company announced the pricing of a public offering of 10 million shares at $0.30 per share, aiming to raise $3 million. The funds will be used for product development, including clinical trials for their lead therapeutic candidate.

Related tickers: RNAZ.

Read Full Article

Trending Tickers

Please sign in to view